We developed this blog as a practical guide for sponsors, CROs, research institutions, and ethics committees (ECs) to successfully adopt eConsent. Learn more:
Although the overall benefits of these products likely outweigh their potential risks, the FDA is investigating the risk of T-cell malignancy with serious outcomes. Read our summary of the recent FDA update here:
The integrity and trustworthiness of research fundamentally depends on the ethical decisions made by IRBs. Learn more in the blog:
The collaboration between scientists & biosafety committees is a cornerstone of responsible, safe, and impactful research. Learn more:
Read our summary of the proposed updates to the NIH Guidelines. Public comments are only open until Oct 10th. Join the conversation and make your input count!
With clinical trial designs growing more complex, can your RTSM keep up? Ensuring your RTSM can adapt is crucial. Read our latest blog on key considerations when choosing an RTSM partner.
Preparing for IBC review is complex and time-consuming. Outsourcing IBC services can help streamline the process. Learn more:
Blogrobgjryan2023-11-02T16:23:27+00:00
